Synopsis
0
KDMF
0
NDC API
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amcill
2. Aminobenzyl Penicillin
3. Aminobenzylpenicillin
4. Ampicillin Sodium
5. Ampicillin Trihydrate
6. Antibiotic Ks R1
7. Antibiotic Ks-r1
8. Ks-r1, Antibiotic
9. Omnipen
10. Penicillin, Aminobenzyl
11. Pentrexyl
12. Polycillin
13. Sodium, Ampicillin
14. Trihydrate, Ampicillin
15. Ukapen
1. 69-53-4
2. Aminobenzylpenicillin
3. Ampicillin Acid
4. Amcill
5. Polycillin
6. Principen
7. Tokiocillin
8. Ampicillin Anhydrous
9. Ampicilline
10. Semicillin
11. Ultrabion
12. Anhydrous Ampicillin
13. Omnipen
14. Ampicillinum
15. Pentrexyl
16. Synpenin
17. Novo-ampicillin
18. D-ampicillin
19. Penbritin
20. D-(-)-ampicillin
21. Adobacillin
22. Amblosin
23. Ampichel
24. Ampicilina
25. Ampifarm
26. Ampipenin
27. Ampiscel
28. Amplacilina
29. Amplipenyl
30. Amplisom
31. Amplital
32. Bonapicillin
33. Britacil
34. Campicillin
35. Copharcilin
36. Delcillin
37. Divercillin
38. Doktacillin
39. Duphacillin
40. Grampenil
41. Guicitrina
42. Lifeampil
43. Norobrittin
44. Orbicilina
45. Penbristol
46. Penbrock
47. Penicline
48. Pentrexl
49. Princillin
50. Racenacillin
51. Rosampline
52. Roscillin
53. Servicillin
54. Sumipanto
55. Texcillin
56. Totalciclina
57. Trifacilina
58. Ultrabron
59. Viccillin
60. Acillin
61. Amfipen
62. Ampicil
63. Ampikel
64. Ampimed
65. Ampisyn
66. Ampivax
67. Ampivet
68. Amplin
69. Binotal
70. Morepen
71. Nuvapen
72. Penimic
73. Pensyn
74. Pentrex
75. Ponecil
76. Tolomol
77. Totapen
78. Vampen
79. Cimex
80. Supen
81. Ampicillin Anhydrate
82. Totacillin
83. Pfizerpen A
84. Amipenix S
85. Ampi-bol
86. Sk-ampicillin
87. Amfipen V
88. Pen Ampil
89. Qidamp
90. Ampi-tab
91. D-cillin
92. Olin Kid
93. Ro-ampen
94. Ampi-co
95. Austrapen
96. Pen A
97. Ampicillina [dcit]
98. Bayer 5427
99. Abpc
100. Ampicillin, Anhydrous
101. Ampicilina [inn-spanish]
102. Ampicilline [inn-french]
103. Ampicillinum [inn-latin]
104. Ampicin
105. D-(-)-alpha-aminopenicillin
106. Deripen
107. Wypicil
108. Alpen
109. Ay-6108
110. Ampicillin A
111. D-(-)-alpha-aminobenzylpenicillin
112. Polycillin-n
113. Totacillin-n
114. Penbritin-s
115. Omnipen-n
116. Brl 1341
117. P-50
118. Penbritin Syrup
119. Semicillin R
120. Nsc-528986
121. D-(-)-6-(alpha-aminophenylacetamido)penicillanic Acid
122. Brl-1341
123. Ks-r1
124. Penbritin Paediatric
125. Ampicillin (anhydrous)
126. Redicilin
127. Ab-pc
128. 6-(d(-)-alpha-aminophenylacetamido)penicillanic Acid
129. Guicitrine
130. Ampen
131. Nsc 528986
132. Ab-pc Sol
133. C16h19n3o4s
134. Chebi:28971
135. Ampicillin Hydrate
136. Alpha-aminobenzylpenicillin
137. 6-(d-(2-amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid
138. Mls000028405
139. (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
140. (2s,5r,6r)-6-{[(2r)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
141. Ampicillina
142. Hi 63
143. Ukapen
144. Pfizerpen-a
145. Wy-5103
146. Ampi
147. Poly-cillin
148. 7c782967rd
149. (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid
150. P 50
151. Sq 17382
152. Wy 5103
153. Penicillin, (aminophenylmethyl)-
154. Smr000058352
155. Ampicillin Base
156. Mfcd00005175
157. Dsstox_cid_2602
158. Ay 6108
159. Dsstox_rid_76654
160. Dsstox_gsid_22602
161. Polyflex (veterinary)
162. Ampicillanyl
163. Ampicillin [usan:ban:inn:jan]
164. Cas-69-53-4
165. (2s,5r,6r)-6-[(r)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
166. (2s,5r,6r)-6-{[(2r)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
167. Omnipen (tn)
168. Totacillin (sodium)
169. Ba 7305
170. Hsdb 3009
171. Ampicillin (usp/inn)
172. Einecs 200-709-7
173. Vidopen
174. Vidocillin
175. Marcillin
176. Pentritin
177. Nsc528986
178. D-(-)-.alpha.-aminobenzylpenicillin
179. Unii-7c782967rd
180. Ampicillin,(s)
181. Ncgc00018160-02
182. (2s,5r,6r)-6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
183. (2s,5r,6r)-6-[[(2r)-2-amino-2-phenyl-acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
184. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2alpha,5alpha,6beta(s*)))-
185. Ampicillin [usan:usp:inn:ban:jan]
186. Spectrum_000050
187. 1h8s
188. Ay 6108
189. Ampicillin [mi]
190. Ampicillin [inn]
191. D-a-aminobenzylpenicillin
192. Opera_id_1630
193. Prestwick0_000114
194. Prestwick1_000114
195. Prestwick2_000114
196. Prestwick3_000114
197. Spectrum2_000769
198. Spectrum3_000301
199. Spectrum4_000149
200. Spectrum5_000814
201. Ampicillin [hsdb]
202. Ampicillin [iarc]
203. Ampicillin [usan]
204. Ampicillin [vandf]
205. Chembl174
206. Epitope Id:115008
207. Epitope Id:116057
208. Ec 200-709-7
209. Ampicillin [mart.]
210. Schembl3526
211. Ampicillin [usp-rs]
212. Ampicillin [who-dd]
213. Ampicillin [who-ip]
214. Bspbio_000128
215. Bspbio_001862
216. Kbiogr_000598
217. Kbioss_000430
218. Anhydrous Ampicillin (jp17)
219. Mls001074168
220. Bidd:gt0184
221. Divk1c_000466
222. Spbio_000818
223. Spbio_002067
224. Ampicillin, Analytical Standard
225. D-(-)-a-aminobenzylpenicillin
226. Bpbio1_000142
227. Dtxsid4022602
228. Chebi:53713
229. Gtpl10896
230. Kbio1_000466
231. Kbio2_000430
232. Kbio2_002998
233. Kbio2_005566
234. Kbio3_001362
235. Ampicillin [ep Monograph]
236. Ninds_000466
237. Ampicillin [usp Monograph]
238. Anhydrous Ampicillin [jan]
239. Hms2090i11
240. Hms2233h23
241. Ampicillin Acid; Principen; Amcill
242. Ampicillinum [who-ip Latin]
243. Hy-b0522
244. Zinc3830218
245. Tox21_113049
246. Tox21_301416
247. Bdbm50350465
248. Ampicillin Anhydrous [who-ip]
249. Akos015888156
250. Tox21_113049_1
251. Ac-8805
252. Db00415
253. 6beta-[(2r)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylic Acid
254. Idi1_000466
255. Smp1_000211
256. Ampicillin Anhydrous [green Book]
257. Ncgc00023282-05
258. Ncgc00023282-06
259. Ncgc00023282-21
260. Ncgc00178944-03
261. Ncgc00248937-01
262. Ncgc00255127-01
263. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, D-(-)-
264. Ba166034
265. Sbi-0051283.p003
266. 6-(a-aminophenylacetamido)penicillanic Acid
267. Sultamicillin Impurity C [ep Impurity]
268. C06574
269. D00204
270. 6-[d(-)-a-aminophenylacetamido]penicillanic Acid
271. A936108
272. Ampicillin Anhydrous, Pharmaceutical Grade
273. Q244150
274. 6-d(-)-alpha-aminophenylacetamido-penicillanic Acid
275. Piperacillin Sodium Impurity A [ep Impurity]
276. Brd-k68432770-001-08-0
277. Ampicillin, Anhydrous, 96.0-100.5% (anhydrous Basis)
278. Ampicillin, United States Pharmacopeia (usp) Reference Standard
279. Anhydrous Ampicillin, British Pharmacopoeia (bp) Reference Standard
280. Ampicillin, Anhydrous, European Pharmacopoeia (ep) Reference Standard
281. (2s,5r,6r)-6-(((r,e)-2-amino-1-hydroxy-2-phenylethylidene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
282. (2s,5r,6r)-6-[(r)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid
283. (2s,5r,6r)-6-{[(2r)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic
284. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((2r)-aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s,5r,6r)-
285. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-
286. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid,6-[[(2r)-aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-, Trihydrate,(2s,5r,6r)-
287. 6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 9ci
288. Ampicillin; D(-)-alpha-aminobenzylpenicillin; 6-[d(-)-alpha-aminophenyllacetamido]penicillanic Acid
| Molecular Weight | 349.4 g/mol |
|---|---|
| Molecular Formula | C16H19N3O4S |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 349.10962727 g/mol |
| Monoisotopic Mass | 349.10962727 g/mol |
| Topological Polar Surface Area | 138 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 562 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Ampicillin sodium |
| Drug Label | Ampicillin for Injection, USP the monosodium salt of [2S-[2,5,6(S*)]]-6- [(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, is a synthetic penicillin for intramuscular or intravenous use. The pha... |
| Active Ingredient | Ampicillin sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 250mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Istituto Bio Ita Spa; Antibiotice; Hanford Gc; Acs Dobfar Spa; Aurobindo Pharma; Strides Arcolab; Sandoz; Agila Speclts |
| 2 of 2 | |
|---|---|
| Drug Name | Ampicillin sodium |
| Drug Label | Ampicillin for Injection, USP the monosodium salt of [2S-[2,5,6(S*)]]-6- [(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, is a synthetic penicillin for intramuscular or intravenous use. The pha... |
| Active Ingredient | Ampicillin sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 2gm base/vial; eq 125mg base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 250mg base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Istituto Bio Ita Spa; Antibiotice; Hanford Gc; Acs Dobfar Spa; Aurobindo Pharma; Strides Arcolab; Sandoz; Agila Speclts |
Penicillins
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
FOR MILD TO MODERATELY SEVERE DISEASE, ORAL...ADULTS...1-4 G/DAY, DIVIDED INTO EQUAL PORTIONS...EVERY 6 HR. FOR SEVERE INFECTIONS...BEST TO ADMIN... PARENTERALLY...6-12 G/DAY. ...MENINGITIS REQUIRES...300-400 MG/KG/DAY PARENTERALLY (IN EQUALLY DIVIDED PORTIONS...EVERY 4 HR) FOR CHILDREN, & 12 G OR MORE/DAY FOR ADULTS.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1079
DOSE VARIES WITH TYPE & SEVERITY OF INFECTION...RENAL FUNCTION &...AGE. FOR CHILDREN.../NOT/ ON BASIS OF BODY WT OR SURFACE AREA; BECAUSE DRUG...EXCRETED MAINLY BY KIDNEY ...RENAL FUNCTION TO GREAT EXTENT DETERMINES DOSE. VERY YOUNG BABIES...REQUIRE SMALL DOSES ...CHILDREN 3-4 YR.../DOSE/ ALMOST AS LARGE AS...ADULTS.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1079
Ampicillin /is/ indicated in the treatment of acute otitis media caused by susceptible organisms. /Included in US product labeling/
USP Convention. USPDI - Drug Information for the Health Care Professional. 15 th ed. Volume 1. Rockville, MD: United States Pharmacopeial Convention, Inc., 1995. (Plus updates.), p. 2149
For more Therapeutic Uses (Complete) data for AMPICILLIN (18 total), please visit the HSDB record page.
IN 1 INSTANCE, FATAL PSEUDOMEMBRANOUS COLITIS OCCURRED FOLLOWING 5 DAYS OF ORAL AMPICILLIN THERAPY IN DOSAGE OF 2 G DAILY. VERY RARELY, AMPICILLIN HAS PRODUCED INTERSTITIAL NEPHRITIS; 1 CASE OF INTERSTITIAL NEPHRITIS REPORTEDLY PROGRESSED TO ACUTE RENAL FAILURE. ...CRYSTALLURIA HAS BEEN REPORTED...
American Hospital Formulary Service. Volumes I and II. Washington, DC: American Society of Hospital Pharmacists, to 1984., p. 8:12:16
PERIODIC ASSESSMENT OF RENAL, HEPATIC & HEMATOPOIETIC FUNCTION SHOULD BE CONDUCTED DURING PROLONGED THERAPY, ESP IN PREMATURE, NEWBORN & OTHER INFANTS.
American Hospital Formulary Service. Volumes I and II. Washington, DC: American Society of Hospital Pharmacists, to 1984., p. 8:12:16
ABSORPTION EFFICIENCY & RATE OF ELIMINATION OF AMPICILLIN...DECR IN PT WITH SHIGELLOSIS. POOR ABSORPTION...GENERALLY OBSERVED IN YOUNGER PATIENTS WITH MARKED DIARRHEA. ... DELAYED EXCRETION. MARKED RETENTION...IN PLASMA...NOTED IN PT WITH RENAL FAILURE.
The Chemical Society. Foreign Compound Metabolism in Mammals Volume 3. London: The Chemical Society, 1975., p. 169
NATIONAL REGISTRY OF POSSIBLE DRUG INDUCED OCULAR SIDE EFFECTS ESTABLISHED IN 1975 BY FDA IN ORDER TO MAKE PHYSICIANS AWARE THAT SOME DRUGS SUCH AS AMPICILLIN MAY CAUSE SIDE EFFECTS TO EYE IS DISCUSSED.
HECHT A; DRUG EFFECTS ON EYE; FDA CONSUM (12): 14 (1978)
For more Drug Warnings (Complete) data for AMPICILLIN (16 total), please visit the HSDB record page.
For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
Ampicillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Ampicillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of Ampicillin results from the inhibition of cell wall synthesis and is mediated through Ampicillin binding to penicillin binding proteins (PBPs). Ampicillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA01 - Ampicillin
S - Sensory organs
S01 - Ophthalmologicals
S01A - Antiinfectives
S01AA - Antibiotics
S01AA19 - Ampicillin
Route of Elimination
Ampicillin is excreted largely unchanged in the urine.
INTAKE OF FOOD PRIOR TO INGESTION OF AMPICILLIN RESULTS IN LESS COMPLETE ABSORPTION. ... /IT/ APPEARS IN BILE, UNDERGOES ENTEROHEPATIC CIRCULATION & IS EXCRETED IN...FECES. BILIARY CONCN...DEPENDENT ON INTEGRITY OF GALLBLADDER & ITS DUCTS.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1079
Ampicillin is distributed to liver, bile, muscle, kidney, crop, and fat following absorption from the GI or injection site. Ampicillin has been used therapeutically and prophylactically for avian salmonellosis with promising results. ... Ampicillin is excreted in bile.
Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 735
Anhydrous ampicillin and ampicillin trihydrate are generally stable in the presence of acidic gastric secretions, and 30-55% of an oral dose of the drugs is absorbed from the GI tract in fasting adults. Although peak serum concn may occur as soon as 1 hr after administration, the maximum serum concn is usually attained in approx 2 hr.
McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 298
Two hr after oral administration of 250 mg of ampicillin in fasting individuals, average peak serum concn of 1.8-2.9 ug/ml are attained. A 500-mg oral dose results in average peak serum concn of 3-6 ug/ml. Concn of the antibiotic in serum are less than 1 ug/ml 6 hr after a 500-mg oral dose.
McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 298
For more Absorption, Distribution and Excretion (Complete) data for AMPICILLIN (16 total), please visit the HSDB record page.
AMPICILLIN IS DEGRADED BY PENICILLINASE...
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1144
YIELDS ALPHA-AMINOBENZYLPENICILLOIC ACID IN BACILLUS, IN PENICILLIUM, AND L-PHENYLGLYCINE IN ESCHERICHIA. /FROM TABLE/
Goodwin, B.L. Handbook of Intermediary Metabolism of Aromatic Compounds. New York: Wiley, 1976., p. A-34
Healthy subjects metabolize about 20% of a given dose (250-500 mg) of ampicillin. Within 12 hr, 7% of the total dose is excreted as metabolites in urine ... Ampicillin is metabolized to 5R,6R-penicilloic acid and 5S,6R-penicilloic acid ... and to piperazine-2,5-dione after oral intake ... Other, unidentified metabolites have been reported ... .
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V50 160
The half-life of all aminopenicillins is approximately 60-90 minutes.
Booth, N.H., L.E. McDonald (eds.). Veterinary Pharmacology and Therapeutics. 5th ed. Ames, Iowa: Iowa State University Press, 1982., p. 735
Following ip injection ... the serum half-life /of ampicillin/ was estimated to be 27 min ... .
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V50 157 (1990)
... /ampicillin's/ plasma half-time is usually 1-2 hr ... but is longer in elderly people ... In patients with renal failure, the half-time was as long as 20 hr ... .
IARC. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Geneva: World Health Organization, International Agency for Research on Cancer, 1972-PRESENT. (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V50 160 (1990)
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Ampicillin interferes with an autolysin inhibitor.
SINCE PENICILLIN HAS NO EFFECT ON EXISTING CELL WALLS, BACTERIA MUST BE MULTIPLYING FOR BACTERICIDAL ACTION OF PENICILLIN TO BE MANIFEST. /PENICILLINS/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1135
The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/
Haddad, L.M., Clinical Management of Poisoning and Drug Overdose. 2nd ed. Philadelphia, PA: W.B. Saunders Co., 1990., p. 953
Bactericidal; inhibit bacterial cell wall synthesis. Action is dependent on the ability of penicillins to reach and bind penicillin binding proteins located on the inner membrane of the bacterial cell wall. Penicillin binding proteins (which include transpeptidases, carboxypeptidases, and endopeptidases) are enzymes that are involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Penicillins bind to, and inactivate, penicillin binding proteins, resulting in the weakening of the bacterial cell wall and lysis. /Penicillins/
USP Convention. USPDI - Drug Information for the Health Care Professional. 15 th ed. Volume 1. Rockville, MD: United States Pharmacopeial Convention, Inc., 1995. (Plus updates.), p. 2150
API SUPPLIERS
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13777
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : R2-CEP 1995-031 - Rev 05
Issue Date : 2022-02-21
Type : Chemical
Substance Number : 167
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13212
Submission : 1998-04-30
Status : Active
Type : II
Certificate Number : R1-CEP 1999-188 - Rev 03
Issue Date : 2018-01-15
Type : Chemical
Substance Number : 167
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39728
Submission : 2024-04-06
Status : Active
Type : II
Certificate Number : CEP 2024-308 - Rev 00
Issue Date : 2025-02-19
Type : Chemical
Substance Number : 167
Status : Valid
Registration Number : 307MF10054
Registrant's Address : Industry Zone, Tuoketuo, Hohhot, Inner Mongolia, China
Initial Date of Registration : 2025-04-16
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13516
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13329
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17546
Submission : 2004-07-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13435
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13297
Submission : 1998-09-01
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13516
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13688
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13435
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13329
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13297
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13777
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13212
Submission : 1998-04-30
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : CEP 2024-308 - Rev 00
Status : Valid
Issue Date : 2025-02-19
Type : Chemical
Substance Number : 167
Certificate Number : R0-CEP 2011-090 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2013-03-07
Type : Chemical
Substance Number : 167
Certificate Number : R2-CEP 1995-031 - Rev 05
Status : Valid
Issue Date : 2022-02-21
Type : Chemical
Substance Number : 167
Certificate Number : R1-CEP 1999-188 - Rev 03
Status : Valid
Issue Date : 2018-01-15
Type : Chemical
Substance Number : 167
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
[Japanese Pharmacopoeia] Ampicillin
Registration Number : 218MF11025
Registrant's Address : 12 BONGEUNSA-RO, 114-GIL, GANGNAM-GU, SEOUL, 135-715 KOREA
Initial Date of Registration : 2006-12-28
Latest Date of Registration : 2006-12-28
Registration Number : 302MF10096
Registrant's Address : Industry Zone, Tuoketuo, Hohhot, Inner Mongolia, China
Initial Date of Registration : 2020-08-05
Latest Date of Registration : 2023-01-25
Registration Number : 307MF10054
Registrant's Address : Industry Zone, Tuoketuo, Hohhot, Inner Mongolia, China
Initial Date of Registration : 2025-04-16
Latest Date of Registration : 2025-04-16
Registration Number : 301MF10028
Registrant's Address : No. 20 Yangzi Road, Shijiazhuang Economic and Technological Development Zone, Hebei 0...
Initial Date of Registration : 2019-07-05
Latest Date of Registration : 2019-07-05
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Date of Issue : 2025-07-11
Valid Till : 2028-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Sy. No\'s. 52,53,58,59,61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No\'s. ...
Date of Issue : 2025-07-11
Valid Till : 2028-06-25
Written Confirmation Number : WC-0023
Address of the Firm : Sy. No\'s. 52,53,58,59,61 to 78, 127 & 128, Pydibhimavaram Village & Sy. No\'s. ...
Date of Issue : 2022-08-02
Valid Till : 2025-07-02
Written Confirmation Number : WC-0121
Address of the Firm : Plot No. 68-70, 73-91, 95, 96, 260, 261, IDA, Pashamylaram (village), Patancheru...
Ampicillin Sodium Sterile IP/BP/USP
Date of Issue : 2022-12-20
Valid Till : 2025-12-20
Written Confirmation Number : WC-0470
Address of the Firm : Plot No. 41, S. V. Cooperative Industrial Estate, Bachupally Village & Mandal, B...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF
VMF Number : 5125
Submission : 1986-12-12
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
Bioquim: An European GMP-certified company manufacturing bulk APIs, specializing in sterile lyophilization and chemical synthesis.
About the Company : Bioquim is a European company specializing in bulk oral and sterile APIs for the pharmaceutical industry. With over 40 years of experience, the company supplies corticosteroids, pe...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formula...
About the Company : With more than 60 years of leadership in the fermentation industry, ADL Biopharma provides outstanding contract development and manufacturing services. Our proven track record allo...
About the Company : DPB Pharma is a leading Indian manufacturer of high-quality sterile and oral antibiotic APIs. Our commitment to innovation and unwavering quality has made us a trusted partner for...
About the Company : Gurvey & Berry offers an impressive lineup of bulk raw materials, but we are much more than products by the kilo or tonne. With 4 decades behind us, and our Service First philosoph...
About the Company : HANGZHOU THINK CHEMICAL CO., LTD. (THINKCHEM) is an integrative corporation of trade, research and contract manufacture. With about ten years of business experiences on the marketi...
About the Company : Dorrapharma is engaged in R&D, manufacture and market of intermediate, API (Active Pharmaceutical Ingredients) and formulation. We stick to raise the value both for the company and...
About the Company : We consider our mission to offer pharmaceutical products of high quality at competitive prices and continuously endeavour to build Mutual Trust with our customers, which is a prere...
About the Company : As a professional pharmaceutical manufacturer, Reyoung Pharm. is the first enterprise to manufacture powder for injection in Shandong province. At present, Reyoung Pharm. has the m...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
Avenacy has launched a suite of antibiotic products for injection, including ampicillin, ampicillin and sulbactam, nafcillin, piperacillin and tazobactam.
Lead Product(s): Ampicillin,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Omnipen-N-Generic
Study Phase: Approved FDFProduct Type: Antibiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 17, 2025
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Avenacy Announces Launch of Five Injectable Antibiotic Products in the U.S. Market
Details : Avenacy has launched a suite of antibiotic products for injection, including ampicillin, ampicillin and sulbactam, nafcillin, piperacillin and tazobactam.
Product Name : Omnipen-N-Generic
Product Type : Antibiotic
Upfront Cash : Inapplicable
March 17, 2025
Details:
Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Premature Birth.
Lead Product(s): Ampicillin,Gentamicin Sulfate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Antibiotic
Sponsor: The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | University of Louisville | Sharp Mary Birch Hospital for Women & Newborns | Children's Hospital of Philadelphia | Jefferson Medical College of Thomas Jefferson Universi
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 04, 2023
Lead Product(s) : Ampicillin,Gentamicin Sulfate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : The University of Pittsburgh School of Medicine | Morgan Stanley Children’s Hospital | University of Louisville | Sharp Mary Birch Hospital for Women & Newborns | Children's Hospital of Philadelphia | Jefferson Medical College of Thomas Jefferson Universi
Deal Size : Inapplicable
Deal Type : Inapplicable
NICU Antibiotics and Outcomes (NANO) Follow-up Study
Details : Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Premature Birth.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
August 04, 2023
Details:
Rosuvastatin is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dyslipidemias.
Lead Product(s): Rosuvastatin Calcium,Ampicillin
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 15, 2019
Lead Product(s) : Rosuvastatin Calcium,Ampicillin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Details : Rosuvastatin is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dyslipidemias.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 15, 2019
Details:
Cefazolin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fractures, Open.
Lead Product(s): Cefazolin,Gentamicin Sulfate,Ceftriaxone,Ampicillin,Sulbactam,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area: Orthopedics/Orthopedic Surgery Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Antibiotic
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 18, 2018
Lead Product(s) : Cefazolin, Gentamicin Sulfate, Ceftriaxone, Ampicillin, Sulbactam
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
Details : Cefazolin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Fractures, Open.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
June 18, 2018
Details:
Cephalosporins is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Kidney Calculi.
Lead Product(s): Cephalosporin,Levofloxacin,Clindamycin Hydrochloride,Ampicillin,Gentamicin Sulfate
Therapeutic Area: Nephrology Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 19, 2015
Lead Product(s) : Cephalosporin,Levofloxacin,Clindamycin Hydrochloride,Ampicillin,Gentamicin Sulfate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
Details : Cephalosporins is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Kidney Calculi.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 19, 2015
Details:
Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neonatal Sepsis.
Lead Product(s): Ceftaroline Fosamil,Ampicillin,Aminoglycoside
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: PRA Health Sciences
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 23, 2015
Lead Product(s) : Ceftaroline Fosamil,Ampicillin,Aminoglycoside
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : PRA Health Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
Details : Ceftaroline Fosamil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Neonatal Sepsis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 23, 2015
Details:
Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Intraabdominal Infections.
Lead Product(s): Ampicillin,Metronidazole,Gentamicin Sulfate,Clindamycin Hydrochloride,Piperacillin Sodium,Tazobactam Sodium
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase II/ Phase IIIProduct Type: Antibiotic
Sponsor: Michael Cohen-Wolkowiez
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 26, 2013
Lead Product(s) : Ampicillin, Metronidazole, Gentamicin Sulfate, Clindamycin Hydrochloride, Piperacillin Sodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Partner/Sponsor/Collaborator : Michael Cohen-Wolkowiez
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Intraabdominal Infections.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 26, 2013
Details:
Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Dystonia musculorum deformans type 1.
Lead Product(s): Ampicillin,Inapplicable
Therapeutic Area: Genetic Disease Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Antibiotic
Sponsor: Tyler's Hope for a Dystonia Cure, Inc
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 14, 2011
Lead Product(s) : Ampicillin,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Tyler's Hope for a Dystonia Cure, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Ampicillin for DYT-1 Dystonia Motor Symptoms
Details : Ampicillin is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Dystonia musculorum deformans type 1.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 14, 2011
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Ampiclox 500
Dosage Form : SUS
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Petercillin
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 500X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Petercillin
Dosage Form : CAP
Dosage Strength : 500mg
Packaging : 500X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megamox
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megapen 500
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 15X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megapen 500
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Ampicillin 250Mg & Cloxacillin 250Mg
Brand Name : Cloxam
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 20X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cloxam
Dosage Form : CAP
Dosage Strength : 250mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megamox S
Dosage Form : SUS
Dosage Strength : 125mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Megapen S
Dosage Form : SUS
Dosage Strength : 125mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : AMPICILLIN TRIHYDRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1988-02-25
Application Number : 62882
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : AMPICILLIN TRIHYDRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1988-02-25
Application Number : 62883
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : PRINCIPEN 500
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 50056
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : PRINCIPEN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 250MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 61394
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : PRINCIPEN 125
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 125MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 62151
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : POLYCILLIN
Dosage Form : FOR SUSPENSION;ORAL
Dosage Strength : EQ 125MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 62297
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : TOTACILLIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 60060
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : PFIZERPEN-A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1982-01-01
Application Number : 62050
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : PFIZERPEN-A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 62050
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
AMPICILLIN/AMPICILLIN TRIHYDRATE
Brand Name : AMPICILLIN TRIHYDRATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 61853
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
35
PharmaCompass offers a list of Ampicillin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ampicillin manufacturer or Ampicillin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ampicillin manufacturer or Ampicillin supplier.
PharmaCompass also assists you with knowing the Ampicillin API Price utilized in the formulation of products. Ampicillin API Price is not always fixed or binding as the Ampicillin Price is obtained through a variety of data sources. The Ampicillin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ampicillin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ampicillin, including repackagers and relabelers. The FDA regulates Ampicillin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ampicillin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ampicillin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ampicillin supplier is an individual or a company that provides Ampicillin active pharmaceutical ingredient (API) or Ampicillin finished formulations upon request. The Ampicillin suppliers may include Ampicillin API manufacturers, exporters, distributors and traders.
click here to find a list of Ampicillin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ampicillin DMF (Drug Master File) is a document detailing the whole manufacturing process of Ampicillin active pharmaceutical ingredient (API) in detail. Different forms of Ampicillin DMFs exist exist since differing nations have different regulations, such as Ampicillin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ampicillin DMF submitted to regulatory agencies in the US is known as a USDMF. Ampicillin USDMF includes data on Ampicillin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ampicillin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ampicillin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ampicillin Drug Master File in Japan (Ampicillin JDMF) empowers Ampicillin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ampicillin JDMF during the approval evaluation for pharmaceutical products. At the time of Ampicillin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ampicillin suppliers with JDMF on PharmaCompass.
A Ampicillin CEP of the European Pharmacopoeia monograph is often referred to as a Ampicillin Certificate of Suitability (COS). The purpose of a Ampicillin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ampicillin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ampicillin to their clients by showing that a Ampicillin CEP has been issued for it. The manufacturer submits a Ampicillin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ampicillin CEP holder for the record. Additionally, the data presented in the Ampicillin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ampicillin DMF.
A Ampicillin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ampicillin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ampicillin suppliers with CEP (COS) on PharmaCompass.
A Ampicillin written confirmation (Ampicillin WC) is an official document issued by a regulatory agency to a Ampicillin manufacturer, verifying that the manufacturing facility of a Ampicillin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ampicillin APIs or Ampicillin finished pharmaceutical products to another nation, regulatory agencies frequently require a Ampicillin WC (written confirmation) as part of the regulatory process.
click here to find a list of Ampicillin suppliers with Written Confirmation (WC) on PharmaCompass.
Ampicillin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ampicillin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ampicillin GMP manufacturer or Ampicillin GMP API supplier for your needs.
A Ampicillin CoA (Certificate of Analysis) is a formal document that attests to Ampicillin's compliance with Ampicillin specifications and serves as a tool for batch-level quality control.
Ampicillin CoA mostly includes findings from lab analyses of a specific batch. For each Ampicillin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ampicillin may be tested according to a variety of international standards, such as European Pharmacopoeia (Ampicillin EP), Ampicillin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ampicillin USP).
